Boston Scientific Announces Agreement to Acquire Apama Medical
Acquisition to Strengthen Company's Electrophysiology Portfolio and Expand into "Single-Shot" Balloon Pulmonary Vein Isolation Treatments for Patients with Atrial FibrillationBoston Scientific Corporation today announced a definitive agreement to acquire Apama Medical Inc., a...
Edinburgh Molecular Imaging Commences Phase II European Cancer Trial
Novel Compound with Potential for Early Detection and to Guide Treatment of Colorectal CancerEdinburgh Molecular Imaging (EM Imaging), the clinical phase biotechnology company focused on enabling image-guided therapy, announces it has commenced a...
New Models and Approaches to Condition Management Leading to Accelerated Growth of Solutions
New Chilmark Research report assesses maturity of solution features, sets forth rationale for rapid growth.Key healthcare stakeholders are accelerating the adoption of more personalized and holistic approaches to chronic condition management, driven by...
Alzheimer’s Disease: Cannabis Formulation Shows Promise
Known as America's most expensive disease, with an estimated cost to the U.S. economy of 6 billion in 2016, Alzheimer's disease (AD) affects more than 5.3 million Americans.Over the next 20 years, the number of...
FDA approves Mylotarg for treatment of acute myeloid leukemia
The U.S. Food and Drug Administration today approved Mylotarg (gemtuzumab ozogamicin) for the treatment of adults with newly diagnosed acute myeloid leukemia whose tumors express the CD33 antigen (CD33-positive AML). The FDA also...
Sutter Health Collaborates with Qventus to Drive Down Pharmaceutical Costs
The not-for-profit Sutter Health network announced today that it will collaborate with Qventus to use the company's artificial intelligence (AI) platform to enhance inpatient pharmacy operations across its healthcare system.The real-time platform...
Subscribe Now
